<DOC>
	<DOCNO>NCT00948805</DOCNO>
	<brief_summary>This study design evaluate ability gonadotropin release hormone ( GnRh ) agonist prevent rise progesterone control ovarian stimulation vitro fertilization ( IVF ) administration human Chorionic Gonadotropin ( hCG ) first day menses .</brief_summary>
	<brief_title>Evaluation Luteolytic Effect Gonadotropin Releasing Hormone ( GnRH ) Agonist After Administration Human Chorionic Gonadotropin ( hCG ) Initial Follicular Phase Its Influence Prognosis Vitro Fertilization Treatment</brief_title>
	<detailed_description>The aim study evaluate efficacy GnRH agonist prevent functional rescue corpus luteum woman submit controlled ovarian stimulation administration hCG first day menses evaluate effect pregnancy rate ovarian steroidogenesis .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Luteolytic Agents</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>age &gt; 21 &lt; 38 year old polycystic ovarian syndrome risk ovarian hyperstimulation syndrome recurrent abortion endometriosis 3 IVF failure use oral contraceptive pill precede 3 month low response gonadotropin</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>corpus luteum rescue</keyword>
	<keyword>Gonadotropin Releasing Hormone ( GnRH agonist )</keyword>
	<keyword>human Chorionic Gonadotropin ( hCG )</keyword>
	<keyword>infertility</keyword>
	<keyword>pregnancy rate</keyword>
</DOC>